Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Berardi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Immunohematology|May 18, 2016
Weak D type 67 in four related Canadian blood donorsPhilip Berardi, Emma Bessette, Michiko Ng, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
The Clinical Utility of <i>FLT3</i> Mutation Testing in Acute Leukemia: A Canadian ConsensusJulie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, et al.
Transfusion|September 10, 2016
Resolving variable maternal D typing using serology and genotyping in selected prenatal patientsGwen Clarke, Judith Hannon, Philip Berardi, et al.
JACC. Case Reports|January 5, 2022
An Unusual Case of Obstructive ShockSimon Parlow, Matthew Cheung, Louis Verreault-Julien, et al.
Vox Sanguinis|December 23, 2023
The selection and preparation of red cell components for intrauterine transfusion: A national surveyMelanie Bodnar, Lani Lieberman, Valerie Arsenault, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 20, 2026
Solving the Puzzle of Hans' Algorithm (HA) Methodological Shortcomings: Canadian Harmonization of Hans' Algorithm for Diffuse Large B-Cell Lymphoma (DLBCL) and Development of Fit-for-Purpose Modified Hans' Algorithm (mHA)Emina Torlakovic, Ariz Akhter, Allam Shawwa, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Transplantation and Cellular Therapy|January 2, 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression ModelsAshish Narayan Masurekar, Kelly M Burkett, Arya Rahgozar, et al.
European Journal of Haematology|June 10, 2019
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignanciesMichael A Levy, Stephanie Santos, Jennifer Kerkhof, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunohematology|May 18, 2016
Weak D type 67 in four related Canadian blood donorsPhilip Berardi, Emma Bessette, Michiko Ng, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
The Clinical Utility of <i>FLT3</i> Mutation Testing in Acute Leukemia: A Canadian ConsensusJulie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, et al.
Transfusion|September 10, 2016
Resolving variable maternal D typing using serology and genotyping in selected prenatal patientsGwen Clarke, Judith Hannon, Philip Berardi, et al.
JACC. Case Reports|January 5, 2022
An Unusual Case of Obstructive ShockSimon Parlow, Matthew Cheung, Louis Verreault-Julien, et al.
Vox Sanguinis|December 23, 2023
The selection and preparation of red cell components for intrauterine transfusion: A national surveyMelanie Bodnar, Lani Lieberman, Valerie Arsenault, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 20, 2026
Solving the Puzzle of Hans' Algorithm (HA) Methodological Shortcomings: Canadian Harmonization of Hans' Algorithm for Diffuse Large B-Cell Lymphoma (DLBCL) and Development of Fit-for-Purpose Modified Hans' Algorithm (mHA)Emina Torlakovic, Ariz Akhter, Allam Shawwa, et al.
Transfusion Medicine (Oxford, England)|May 21, 2020
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation riskAndrew W Shih, Matthew T S Yan, Allahna L Elahie, et al.
Transplantation and Cellular Therapy|January 2, 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression ModelsAshish Narayan Masurekar, Kelly M Burkett, Arya Rahgozar, et al.
European Journal of Haematology|June 10, 2019
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignanciesMichael A Levy, Stephanie Santos, Jennifer Kerkhof, et al.
Pageof 2